Showing results (1-10 of 796) with videos related to
Sort By:
Pageof 80
La Clinica Terapeutica|February 28, 1990
[ACE-inhibitors: physiologic premises and pharmacologic profiles]A Marino, G Schettini, T Florio, et al.Journal of Neurochemistry|November 1, 1992
Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivityG Schettini, C Ventra, T Florio, et al.La Clinica Terapeutica|December 15, 1990
[The cardiac toxicity of antidepressive thymoleptics. Experimental and clinical studies]A Marino, G Schettini, C VentraBrain Research|July 17, 1989
Somatostatin inhibition of adenylate cyclase activity in different brain areasG Schettini, T Florio, O Meucci, et al.Brain Research|August 23, 1991
Age-related alterations of somatostatin gene expression in different rat brain areasT Florio, C Ventra, A Postiglione, et al.Pharmacological Research|March 1, 1990
Fipexide improvement of cognitive functions in rat: behavioural and neurochemical studiesA Marino, T Florio, O Meucci, et al.Journal of Molecular Endocrinology|August 1, 1990
Adenosine and its analogue (-)-N6-R-phenyl-isopropyladenosine modulate anterior pituitary adenylate cyclase activity and prolactin secretion in the ratG Schettini, E Landolfi, O Meucci, et al.Behavioural Pharmacology|February 1, 1991
Dihydroergotoxine treatment improves active avoidance performance and increases dopamine-stimulated adenylate cyclase activity, in young and aged ratsT. Florio, C. Ventra, A. Rapanà, et al.Pharmacology, Biochemistry, and Behavior|September 1, 1992
Molecular mechanisms mediating the effects of L-alpha-glycerylphosphorylcholine, a new cognition-enhancing drug, on behavioral and biochemical parameters in young and aged ratsG Schettini, C Ventra, T Florio, et al.Acta Neurologica|August 1, 1991
Role of interleukin-6 in the neuroendocrine systemG Schettini, M Grimaldi, E Landolfi, et al.Pageof 80